Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New EU research projects approved:

This article was originally published in Clinica

Executive Summary

Funds totalling some E500 million ($500 million) are being allocated to 307 new research projects under the European Commission's quality of life and management of living resources programme. This is part of the European Union's fifth framework programme, and will cover subjects including genome research and cell factories. In the area of infectious disease, projects will aim to identify new anti-infective interventions and diagnostics and to develop the research base for epidemiological monitoring and rational public health practices. The cell factory programme, meanwhile, covers 26 health projects including neural regeneration, genes susceptible to melanoma and new biomarkers for skin damage.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073063

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel